A funding round brought in $9.5 million for Boston-based Confer Health, which plans to use the money for developing at-home diagnostic devices that come with a mobile app, a reusable analyzer and interchangeable cartridges. The company is making an at-home device for strep throat detection and is looking to release its Confer Conceive fertility device in 2019.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.